![Kasim Kutay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kasim Kutay
Directeur/Membre du Conseil chez
NOVO NORDISK A/S
Fortune : 75 159 $ au 31/08/2026
Profil
Mr. Kasim Kutay is a CEO at Novo Principal Investments, a Chief Executive Officer at Novo Holdings A/S (Denmark) and a Chief Executive Officer at Novo Holdings A/S.
He is on the Board of Directors at Novonesis (Novozymes A/S), Novo Nordisk A/S, Chelsea & Westminster Hospital Nhs Foundation Trust and Momentum Energy Group A/S.
From 2009 to 2016, Mr. Kutay was a Partner and member of the Global Management Committee of Moelis & Co. From 1989 to 2007 he held a number of positions at Morgan Stanley, including chair of the European Healthcare Group.
He was member of the Board of Trustees of Northwick Park Institute for Medical Research, UK, from 2005 to 2016.
He was member of the Board of Governors from 2006 to 2011 and the Investment Committee from 2011 to 2016 of the School of Oriental and African Studies (SOAS), UK.
Mr. Kutay is a UK national and holds a MSc.
and BSc.
in Economics from the LSE (London School of Economics and Political Science).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0% | 31/12/2025 | 1 046 ( 0% ) | 75 159 $ | 31/08/2026 |
Postes actifs de Kasim Kutay
| Sociétés | Poste | Début |
|---|---|---|
| NOVO NORDISK A/S | Directeur/Membre du Conseil | 23/03/2017 |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives. | Directeur Général | 01/08/2016 |
Chelsea & Westminster Hospital Nhs Foundation Trust
 Chelsea & Westminster Hospital Nhs Foundation Trust Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides hospital services | Directeur/Membre du Conseil | - |
Momentum Gruppen A/S
 Momentum Gruppen A/S Electric UtilitiesUtilities Provides and administrates solar and wind projects | Directeur/Membre du Conseil | - |
Novo Holdings A/S (Denmark)
 Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Directeur Général | 01/09/2016 |
Novo Principal Investments
 Novo Principal Investments Investment ManagersFinance Novo Principal invests in public and private companies located across Europe and North America. The firm focuses on companies operating in the fields of healthcare and life science sectors. It provides financing for later stage capital requirements. | Directeur Général | 01/08/2016 |
Anciens postes connus de Kasim Kutay
| Sociétés | Poste | Fin |
|---|---|---|
| EVOTEC SE | Directeur/Membre du Conseil | 22/06/2022 |
| CONVATEC GROUP PLC | Directeur/Membre du Conseil | 03/07/2018 |
Moelis & Co. LLC
 Moelis & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/08/2016 |
| ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ ░░░ ░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Kasim Kutay
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
Moelis & Co. LLC
Moelis & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Active Biotech AB
 Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
Novo Holdings A/S (Denmark)
Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Finance |
Northwick Park Institute For Medical Research
 Northwick Park Institute For Medical Research Miscellaneous Commercial ServicesCommercial Services Operates as a charity-based independent medical research institute | Commercial Services |
School of Oriental & African Studies
 School of Oriental & African Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London School of Economics & Political Science
 London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moelis Asset Management LP
 Moelis Asset Management LP Investment Banks/BrokersFinance Provides investment banking services | Finance |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Novo Principal Investments
Novo Principal Investments Investment ManagersFinance Novo Principal invests in public and private companies located across Europe and North America. The firm focuses on companies operating in the fields of healthcare and life science sectors. It provides financing for later stage capital requirements. | Finance |
Sun Group Global | |
Moelis & Co. (UK) LLP
 Moelis & Co. (UK) LLP Investment Banks/BrokersFinance Provides brokerage services | Finance |
Convatec Group Plc
 Convatec Group Plc Medical SpecialtiesHealth Technology Develops, manufactures, and markets medical products and technologies | Health Technology |
Momentum Gruppen A/S
Momentum Gruppen A/S Electric UtilitiesUtilities Provides and administrates solar and wind projects | Utilities |
Novo Holdings A/S (Investment Company)
Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives. | Finance |
Chelsea & Westminster Hospital Nhs Foundation Trust
Chelsea & Westminster Hospital Nhs Foundation Trust Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that provides hospital services | Commercial Services |
